A long-term prospective study of varicella vaccine in healthy children

Pediatrics

Volumn 100, Issue 5, 1997, Pages 761-766

  Johnson, Candice E ^a   Stancin, Terry ^a   Fattlar, Deborah ^a   Rome, Leonard P ^b   Kumar, Mary L ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CHICKENPOX; CHILD; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMORAL IMMUNITY; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECIPIENT; SEROCONVERSION; VARICELLA ZOSTER VIRUS;

ADOLESCENT; ANTIBODIES, VIRAL; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; FLUORESCENT ANTIBODY TECHNIQUE; HERPESVIRUS 3, HUMAN; HUMANS; INFANT; PROSPECTIVE STUDIES;

EID: 0030777673     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.100.5.761     Document Type: Article

References (22)

1. Krause PR, Klinman DM. Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine. J Pediatr. 1995;127:518-525
2. Jones CP. Recommendations for using varicella vaccine. Infect Dis Child. 1996;9:13
3. Plotkin SA. Varicella vaccine. Pediatrics. 1996;97:251-253
4. Halloran ME, Cochi SL, Lieu TA, Wharton M, Fehrs L. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the US. Am J Epidemiol. 1994;140:81-104
5. Peterson CL, Mascola L, Chao SM, et al. Children hospitalized for varicella: a prevaccine review. J Pediatr. 1996;129:529-536
6. Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J Infect Dis. 1995;172:706-712
7. Arvin AM. The T-lymphocyte response to varicella zoster virus and its relevance to vaccine development. Rev Med Virol. 1994;4:161-175
8. Johnson CE, Shurin PA, Fattlar D, et al. Live attenuated varicella vaccine in healthy 12-to 24-month-old children. Pediatrics. 1988;81:512-518
9. Wasmuth EH, Miller WJ. Sensitive enzyme-linked immunosorbent assay for antibody to varicella zoster virus using purified VZV glycoprotein antigen. J Med Virol 1990;32:189-193
10. White CJ, Kuter BJ, Ngai A, et al. Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response. Pediatr Infect Dis J. 1992;11:19-23
11. Clements DA, Armstrong CB, Ursano AM, Moggio MM, Walter EB, Wilfert CM. Over five-year follow up of Oka/Merck varicella vaccine recipients in 465 infants and adolescents. Pediatr Infect Dis J. 1995;14: 874-879
12. Johnson CE, Rome LP, Stancin T, Kumar ML. Humoral immunity and clinical reinfections following varicella vaccine in healthy children. Pediatrics. 1989;84:418-421
13. Watson BM, Piercy SA, Plotkin SA, Starr SE. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics. 1993;91:17-22
14. Bernstein HH, Rothstein EP, Pennridge Pediatric Associates, et al. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. Pediatrics. 1993;92:833-837
15. Asano Y, Nagai T, Miyata T, et al. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine. Pediatrics. 1985;75: 667-671
16. Asano Y, Suga S, Yoshikawa T, et al. Experience and reason: 20-year follow-up of protective immunity of the Oka strain live varicella vaccine. Pediatrics. 1994;94:524-526
17. Centers for Disease Control and Prevention. Prevention of varicella. MMWR. 1996;45(RR-11):1-36
18. Ferfuson NM, Anderson RM, Garnet GP. Mass vaccination to control chickenpox: the influence of zoster. Proc Natl Acad Sci USA. 1996;93:7235
19. Watson B, Gupta R, Randall T, Starr S. Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine. J Infect Dis. 1994;169:197-199
20. Alper CA, Kruskall MS, Marcus-Bagley D, et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med. 1989;321:708-712
21. Gershon AA. Varicella vaccine: its past, present and future. Pediatr Infect Dis J. 1995;14:742-744
22. Lieu TA, Cochi SL, Block SB, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA. 1994;271: 375-381